Metabolic Syndrome and the Risk of Prostate Cancer in Finnish Men: A Population-Based Study

Objective: Individual components of metabolic syndrome have been linked to an increased risk for prostate cancers. We hypothesized that metabolic syndrome itself could confer an increased risk for incident prostate cancer. Methods: The participants were a population-based sample of 1,880 men from ea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2004-10, Vol.13 (10), p.1646-1650
Hauptverfasser: LAUKKANEN, Jari A, LAAKSONEN, David E, NISKANEN, Leo, PUKKALA, Eero, HAKKARAINEN, Anna, SALONEN, Jukka T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1650
container_issue 10
container_start_page 1646
container_title Cancer epidemiology, biomarkers & prevention
container_volume 13
creator LAUKKANEN, Jari A
LAAKSONEN, David E
NISKANEN, Leo
PUKKALA, Eero
HAKKARAINEN, Anna
SALONEN, Jukka T
description Objective: Individual components of metabolic syndrome have been linked to an increased risk for prostate cancers. We hypothesized that metabolic syndrome itself could confer an increased risk for incident prostate cancer. Methods: The participants were a population-based sample of 1,880 men from eastern Finland without history of cancer or diabetes mellitus at baseline. Results: The metabolic syndrome (WHO criteria) was present in 357 (19%) of subjects. During an average follow-up of 13 years, a total of 183 cancers occurred, of which 56 were due to prostate cancer. The metabolic syndrome at baseline was related to a 1.9-fold (95% confidence interval, 1.1-3.5) risk of prostate cancer after adjustment for age, alcohol consumption, physical fitness, and energy, fat, fiber, calcium, vitamin E, and α-linolenic acid intake. The association between metabolic syndrome and risk of prostate cancer was stronger among overweight and obese men with a body mass index ≥27 kg/m 2 (adjusted relative risk, 3.0; 95% confidence interval, 1.2-7.3) than in lighter men (relative risk, 1.8; 95% confidence interval, 0.7-4.7). Conclusions: Middle-aged men with the metabolic syndrome were more likely to develop prostate cancer in this prospective population-based study. This finding suggests that efforts to curb the epidemic of overweight and sedentary lifestyle and the accompanying metabolic syndrome may decrease the risk for prostate cancer.
doi_str_mv 10.1158/1055-9965.1646.13.10
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66932738</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66932738</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-87a65000b6fe1e39300009f98fb67dc80c5120d1a5182fdfed9bfe669582e1023</originalsourceid><addsrcrecordid>eNpFkEtv1DAQgC0Eog_4Bwj5AhKHLHYcv7iVFQWkVlQUThwsxx4TQ9bZ2onQ_vt6u4t6mtHom9eH0CtKVpRy9Z4SzhutBV9R0YkVZStKnqBTyplqpOT8ac3_IyforJQ_hBCpOX-OTijvhNCqPUW_rmG2_TRGh293yedpA9gmj-cB8PdY_uIp4Js8ldnOgNc2Ocg4JnwZU4plwNeQPuALfDNtl9HOcUrNR1vA49t58bsX6FmwY4GXx3iOfl5--rH-0lx9-_x1fXHVuE7quVHSCl5v60UACkyzmhMdtAq9kN4p4jhtiaeWU9UGH8DrPkC9n6sWKGnZOXp7mLvN090CZTabWByMo00wLcVUlLWSqQp2B9DVj0qGYLY5bmzeGUrMXqrZGzN7Y2Yv1VBWK7Xt9XH-0m_APzYdLVbgzRGwxdkx5OoplkdOUNlxKSr37sAN8ffwL2Yw7sFohgI2u-Gw72E1uwf6o4we</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66932738</pqid></control><display><type>article</type><title>Metabolic Syndrome and the Risk of Prostate Cancer in Finnish Men: A Population-Based Study</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>LAUKKANEN, Jari A ; LAAKSONEN, David E ; NISKANEN, Leo ; PUKKALA, Eero ; HAKKARAINEN, Anna ; SALONEN, Jukka T</creator><creatorcontrib>LAUKKANEN, Jari A ; LAAKSONEN, David E ; NISKANEN, Leo ; PUKKALA, Eero ; HAKKARAINEN, Anna ; SALONEN, Jukka T</creatorcontrib><description>Objective: Individual components of metabolic syndrome have been linked to an increased risk for prostate cancers. We hypothesized that metabolic syndrome itself could confer an increased risk for incident prostate cancer. Methods: The participants were a population-based sample of 1,880 men from eastern Finland without history of cancer or diabetes mellitus at baseline. Results: The metabolic syndrome (WHO criteria) was present in 357 (19%) of subjects. During an average follow-up of 13 years, a total of 183 cancers occurred, of which 56 were due to prostate cancer. The metabolic syndrome at baseline was related to a 1.9-fold (95% confidence interval, 1.1-3.5) risk of prostate cancer after adjustment for age, alcohol consumption, physical fitness, and energy, fat, fiber, calcium, vitamin E, and α-linolenic acid intake. The association between metabolic syndrome and risk of prostate cancer was stronger among overweight and obese men with a body mass index ≥27 kg/m 2 (adjusted relative risk, 3.0; 95% confidence interval, 1.2-7.3) than in lighter men (relative risk, 1.8; 95% confidence interval, 0.7-4.7). Conclusions: Middle-aged men with the metabolic syndrome were more likely to develop prostate cancer in this prospective population-based study. This finding suggests that efforts to curb the epidemic of overweight and sedentary lifestyle and the accompanying metabolic syndrome may decrease the risk for prostate cancer.</description><identifier>ISSN: 1055-9965</identifier><identifier>EISSN: 1538-7755</identifier><identifier>DOI: 10.1158/1055-9965.1646.13.10</identifier><identifier>PMID: 15466982</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Biological and medical sciences ; Finland - epidemiology ; Humans ; Incidence ; Life Style ; Male ; Medical sciences ; Metabolic Syndrome - complications ; Middle Aged ; Nephrology. Urinary tract diseases ; Obesity ; Prospective Studies ; Prostatic Neoplasms - epidemiology ; Prostatic Neoplasms - etiology ; Risk Factors ; Tumors ; Tumors of the urinary system ; Urinary tract. Prostate gland</subject><ispartof>Cancer epidemiology, biomarkers &amp; prevention, 2004-10, Vol.13 (10), p.1646-1650</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-87a65000b6fe1e39300009f98fb67dc80c5120d1a5182fdfed9bfe669582e1023</citedby><cites>FETCH-LOGICAL-c479t-87a65000b6fe1e39300009f98fb67dc80c5120d1a5182fdfed9bfe669582e1023</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3343,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16174576$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15466982$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LAUKKANEN, Jari A</creatorcontrib><creatorcontrib>LAAKSONEN, David E</creatorcontrib><creatorcontrib>NISKANEN, Leo</creatorcontrib><creatorcontrib>PUKKALA, Eero</creatorcontrib><creatorcontrib>HAKKARAINEN, Anna</creatorcontrib><creatorcontrib>SALONEN, Jukka T</creatorcontrib><title>Metabolic Syndrome and the Risk of Prostate Cancer in Finnish Men: A Population-Based Study</title><title>Cancer epidemiology, biomarkers &amp; prevention</title><addtitle>Cancer Epidemiol Biomarkers Prev</addtitle><description>Objective: Individual components of metabolic syndrome have been linked to an increased risk for prostate cancers. We hypothesized that metabolic syndrome itself could confer an increased risk for incident prostate cancer. Methods: The participants were a population-based sample of 1,880 men from eastern Finland without history of cancer or diabetes mellitus at baseline. Results: The metabolic syndrome (WHO criteria) was present in 357 (19%) of subjects. During an average follow-up of 13 years, a total of 183 cancers occurred, of which 56 were due to prostate cancer. The metabolic syndrome at baseline was related to a 1.9-fold (95% confidence interval, 1.1-3.5) risk of prostate cancer after adjustment for age, alcohol consumption, physical fitness, and energy, fat, fiber, calcium, vitamin E, and α-linolenic acid intake. The association between metabolic syndrome and risk of prostate cancer was stronger among overweight and obese men with a body mass index ≥27 kg/m 2 (adjusted relative risk, 3.0; 95% confidence interval, 1.2-7.3) than in lighter men (relative risk, 1.8; 95% confidence interval, 0.7-4.7). Conclusions: Middle-aged men with the metabolic syndrome were more likely to develop prostate cancer in this prospective population-based study. This finding suggests that efforts to curb the epidemic of overweight and sedentary lifestyle and the accompanying metabolic syndrome may decrease the risk for prostate cancer.</description><subject>Biological and medical sciences</subject><subject>Finland - epidemiology</subject><subject>Humans</subject><subject>Incidence</subject><subject>Life Style</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic Syndrome - complications</subject><subject>Middle Aged</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Obesity</subject><subject>Prospective Studies</subject><subject>Prostatic Neoplasms - epidemiology</subject><subject>Prostatic Neoplasms - etiology</subject><subject>Risk Factors</subject><subject>Tumors</subject><subject>Tumors of the urinary system</subject><subject>Urinary tract. Prostate gland</subject><issn>1055-9965</issn><issn>1538-7755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEtv1DAQgC0Eog_4Bwj5AhKHLHYcv7iVFQWkVlQUThwsxx4TQ9bZ2onQ_vt6u4t6mtHom9eH0CtKVpRy9Z4SzhutBV9R0YkVZStKnqBTyplqpOT8ac3_IyforJQ_hBCpOX-OTijvhNCqPUW_rmG2_TRGh293yedpA9gmj-cB8PdY_uIp4Js8ldnOgNc2Ocg4JnwZU4plwNeQPuALfDNtl9HOcUrNR1vA49t58bsX6FmwY4GXx3iOfl5--rH-0lx9-_x1fXHVuE7quVHSCl5v60UACkyzmhMdtAq9kN4p4jhtiaeWU9UGH8DrPkC9n6sWKGnZOXp7mLvN090CZTabWByMo00wLcVUlLWSqQp2B9DVj0qGYLY5bmzeGUrMXqrZGzN7Y2Yv1VBWK7Xt9XH-0m_APzYdLVbgzRGwxdkx5OoplkdOUNlxKSr37sAN8ffwL2Yw7sFohgI2u-Gw72E1uwf6o4we</recordid><startdate>20041001</startdate><enddate>20041001</enddate><creator>LAUKKANEN, Jari A</creator><creator>LAAKSONEN, David E</creator><creator>NISKANEN, Leo</creator><creator>PUKKALA, Eero</creator><creator>HAKKARAINEN, Anna</creator><creator>SALONEN, Jukka T</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041001</creationdate><title>Metabolic Syndrome and the Risk of Prostate Cancer in Finnish Men: A Population-Based Study</title><author>LAUKKANEN, Jari A ; LAAKSONEN, David E ; NISKANEN, Leo ; PUKKALA, Eero ; HAKKARAINEN, Anna ; SALONEN, Jukka T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-87a65000b6fe1e39300009f98fb67dc80c5120d1a5182fdfed9bfe669582e1023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Biological and medical sciences</topic><topic>Finland - epidemiology</topic><topic>Humans</topic><topic>Incidence</topic><topic>Life Style</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic Syndrome - complications</topic><topic>Middle Aged</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Obesity</topic><topic>Prospective Studies</topic><topic>Prostatic Neoplasms - epidemiology</topic><topic>Prostatic Neoplasms - etiology</topic><topic>Risk Factors</topic><topic>Tumors</topic><topic>Tumors of the urinary system</topic><topic>Urinary tract. Prostate gland</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LAUKKANEN, Jari A</creatorcontrib><creatorcontrib>LAAKSONEN, David E</creatorcontrib><creatorcontrib>NISKANEN, Leo</creatorcontrib><creatorcontrib>PUKKALA, Eero</creatorcontrib><creatorcontrib>HAKKARAINEN, Anna</creatorcontrib><creatorcontrib>SALONEN, Jukka T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer epidemiology, biomarkers &amp; prevention</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LAUKKANEN, Jari A</au><au>LAAKSONEN, David E</au><au>NISKANEN, Leo</au><au>PUKKALA, Eero</au><au>HAKKARAINEN, Anna</au><au>SALONEN, Jukka T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolic Syndrome and the Risk of Prostate Cancer in Finnish Men: A Population-Based Study</atitle><jtitle>Cancer epidemiology, biomarkers &amp; prevention</jtitle><addtitle>Cancer Epidemiol Biomarkers Prev</addtitle><date>2004-10-01</date><risdate>2004</risdate><volume>13</volume><issue>10</issue><spage>1646</spage><epage>1650</epage><pages>1646-1650</pages><issn>1055-9965</issn><eissn>1538-7755</eissn><abstract>Objective: Individual components of metabolic syndrome have been linked to an increased risk for prostate cancers. We hypothesized that metabolic syndrome itself could confer an increased risk for incident prostate cancer. Methods: The participants were a population-based sample of 1,880 men from eastern Finland without history of cancer or diabetes mellitus at baseline. Results: The metabolic syndrome (WHO criteria) was present in 357 (19%) of subjects. During an average follow-up of 13 years, a total of 183 cancers occurred, of which 56 were due to prostate cancer. The metabolic syndrome at baseline was related to a 1.9-fold (95% confidence interval, 1.1-3.5) risk of prostate cancer after adjustment for age, alcohol consumption, physical fitness, and energy, fat, fiber, calcium, vitamin E, and α-linolenic acid intake. The association between metabolic syndrome and risk of prostate cancer was stronger among overweight and obese men with a body mass index ≥27 kg/m 2 (adjusted relative risk, 3.0; 95% confidence interval, 1.2-7.3) than in lighter men (relative risk, 1.8; 95% confidence interval, 0.7-4.7). Conclusions: Middle-aged men with the metabolic syndrome were more likely to develop prostate cancer in this prospective population-based study. This finding suggests that efforts to curb the epidemic of overweight and sedentary lifestyle and the accompanying metabolic syndrome may decrease the risk for prostate cancer.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>15466982</pmid><doi>10.1158/1055-9965.1646.13.10</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1055-9965
ispartof Cancer epidemiology, biomarkers & prevention, 2004-10, Vol.13 (10), p.1646-1650
issn 1055-9965
1538-7755
language eng
recordid cdi_proquest_miscellaneous_66932738
source MEDLINE; American Association for Cancer Research; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Biological and medical sciences
Finland - epidemiology
Humans
Incidence
Life Style
Male
Medical sciences
Metabolic Syndrome - complications
Middle Aged
Nephrology. Urinary tract diseases
Obesity
Prospective Studies
Prostatic Neoplasms - epidemiology
Prostatic Neoplasms - etiology
Risk Factors
Tumors
Tumors of the urinary system
Urinary tract. Prostate gland
title Metabolic Syndrome and the Risk of Prostate Cancer in Finnish Men: A Population-Based Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T02%3A18%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolic%20Syndrome%20and%20the%20Risk%20of%20Prostate%20Cancer%20in%20Finnish%20Men:%20A%20Population-Based%20Study&rft.jtitle=Cancer%20epidemiology,%20biomarkers%20&%20prevention&rft.au=LAUKKANEN,%20Jari%20A&rft.date=2004-10-01&rft.volume=13&rft.issue=10&rft.spage=1646&rft.epage=1650&rft.pages=1646-1650&rft.issn=1055-9965&rft.eissn=1538-7755&rft_id=info:doi/10.1158/1055-9965.1646.13.10&rft_dat=%3Cproquest_cross%3E66932738%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66932738&rft_id=info:pmid/15466982&rfr_iscdi=true